Prasenjit Saha

Prasenjit Saha, PhD, is a Research Scientist at Abilita Therapeutics, Inc., since November 2023, and serves as an Editor for Frontiers, specifically as a Review Editor on the Editorial Board of Infectious Agents and Disease. Prasenjit is also an active reviewer for several scientific journals including Frontiers in Cellular and Infection Microbiology, MDPI's International Journal of Environmental Research and Public Health, Journal of Biological Chemistry, PLOS One, and publications under Springer Nature and Portland Press. Prior experience includes roles as a Research Associate and Postdoctoral Researcher at Cleveland Clinic, focusing on G-protein coupled receptors and gut microbial metabolites related to cardiovascular disease. Academic qualifications include a PhD in Biochemistry from the Indian Institute of Science, supported by a Master's degree in Biotechnology and a Bachelor's degree in Microbiology.